Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial. 

 -  2023 
<br/><br/><br/>English 
<br/><br/><label>ISSN: </label>1774-024X 
<br/><br/><label>Standard No.: </label>10.4244/EIJ-D-22-00526 [doi] EIJ-D-22-00526 [pii] 
<br/><br/><label>Subjects--Topical Terms: </label><br/>IN PROCESS -- NOT YET INDEXED
<br/><br/><label>Subjects--Geographic Terms: </label><br/>MedStar Heart & Vascular Institute
<br/><br/><label>Index Terms--Function: </label><br/>Journal Article